Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibiotics
Biotech
Basilea scores $268M BARDA funding for antifungals, antibiotics
In the near term, the company will get $29 million to develop its antifungals fosmanogepix and BAL2062.
James Waldron
Sep 19, 2024 7:45am
Crestone’s antibiotic beats vancomycin at treating C. diff
Sep 5, 2024 3:11pm
Chlamydia in gut cells could require new antibiotic approach
Sep 5, 2024 5:00am
AN2 halves head count, stops phase 3 trial after data disappoint
Aug 9, 2024 5:41am
Pepper chemical prevents hearing loss from powerful antibiotics
Aug 8, 2024 10:40am
New antibiotic kills flesh-eating bacteria in preclinical study
Aug 2, 2024 2:00pm